← Open Payments lookup

DANIEL BEQUILLARD: Open Payments

NPI 1154410041 · PORT ARANSAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,334 in 60 payments from 16 companies in 2025. Trend: 2023 $1,188 · 2024 $919 · 2025 $1,334

Food & beverage: $1,334
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.11$296
Amgen Inc.16$289
AstraZeneca Pharmaceuticals LP8$201
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$104
GlaxoSmithKline, LLC.4$99
Novo Nordisk Inc3$71
ABBVIE INC.3$65
Lilly USA, LLC2$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$30
Boehringer Ingelheim Pharmaceuticals, Inc.1$22

Products named: Kerendia, REPATHA, AIRSUPRA, OTEZLA, CAPLYTA, TRELEGY ELLIPTA, Ozempic, QULIPTA.

Industry payments across TX — which companies pay providers there.